YD Bio (NASDAQ:YDES) Shares Gap Up – Should You Buy?

YD Bio Limited (NASDAQ:YDES)’s share price gapped up before the market opened on Monday . The stock had previously closed at $7.43, but opened at $7.79. YD Bio shares last traded at $7.41, with a volume of 5,606 shares traded.

Analyst Upgrades and Downgrades

YDES has been the subject of a number of research analyst reports. Weiss Ratings reiterated a “sell (d+)” rating on shares of YD Bio in a research note on Monday, December 29th. Wall Street Zen upgraded YD Bio from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of “Sell”.

YD Bio Trading Down 1.5%

The business has a fifty day moving average price of $8.84.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in YD Bio stock. Geode Capital Management LLC boosted its position in shares of YD Bio Limited (NASDAQ:YDES) by 10.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 58,363 shares of the biotechnology company’s stock after buying an additional 5,292 shares during the quarter. Geode Capital Management LLC owned approximately 0.08% of YD Bio worth $711,000 as of its most recent SEC filing.

About YD Bio

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.